Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
60 hedge funds and large institutions have $466M invested in Translate Bio, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 8 closing their positions.
214% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 7
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
56% more capital invested
Capital invested by funds: $298M → $466M (+$168M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
15% more funds holding
Funds holding: 52 → 60 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$24.8M |
| 2 |
FM
Frazier Management
Seattle,
Washington
|
+$17.7M |
| 3 |
RI
RTW Investments
New York
|
+$11.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.17M |
| 5 |
BlackRock
New York
|
+$5.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.63M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.02M |
| 3 |
FI
Fosun International
Hong Kong,
China
|
-$578K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$153K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$146K |
TBIO Hedge Fund Activity: Q2 2019 in Review
60 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q2 2019, worth a combined $466M — up 56% from $298M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new TBIO positions and 8 closed out — a net gain of 10 holders — while 22 added to existing stakes and 7 trimmed.
The largest buyer was Baupost Group, adding an estimated $24.8M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $4.63M sold.
- 60 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q2 2019, up from 52 in Q1 2019.
- Funds reported $466M of Translate Bio, Inc. Common Stock stock for Q2 2019, up 56% quarter-over-quarter.
- 18 funds opened new Translate Bio, Inc. Common Stock positions in Q2 2019 and 8 closed out, a net change of +10 holders.
- The largest Translate Bio, Inc. Common Stock buyer in Q2 2019 was Baupost Group, an estimated $24.8M added.
- The largest Translate Bio, Inc. Common Stock seller in Q2 2019 was Cormorant Asset Management, an estimated $4.63M sold.
Based on aggregated 13F filings for Q2 2019.